139 related articles for article (PubMed ID: 1614968)
1. Use of a pharmacokinetic model incorporating discontinuous gastrointestinal absorption to examine the occurrence of double peaks in oral concentration-time profiles.
Suttle AB; Pollack GM; Brouwer KL
Pharm Res; 1992 Mar; 9(3):350-6. PubMed ID: 1614968
[TBL] [Abstract][Full Text] [Related]
2. Applications and simulations of a discontinuous oral absorption pharmacokinetic model.
Witcher JW; Boudinot FD
Pharm Res; 1996 Nov; 13(11):1720-4. PubMed ID: 8956341
[TBL] [Abstract][Full Text] [Related]
3. Variable gastric emptying and discontinuities in drug absorption profiles: dependence of rates and extent of cimetidine absorption on motility phase and pH.
Langguth P; Lee KM; Spahn-Langguth H; Amidon GL
Biopharm Drug Dispos; 1994 Dec; 15(9):719-46. PubMed ID: 7888602
[TBL] [Abstract][Full Text] [Related]
4. The influence of variable gastric emptying and intestinal transit rates on the plasma level curve of cimetidine; an explanation for the double peak phenomenon.
Oberle RL; Amidon GL
J Pharmacokinet Biopharm; 1987 Oct; 15(5):529-44. PubMed ID: 3694496
[TBL] [Abstract][Full Text] [Related]
5. A modified two-portion absorption model to describe double-peak absorption profiles of ranitidine.
Yin OQ; Tomlinson B; Chow AH; Chow MS
Clin Pharmacokinet; 2003; 42(2):179-92. PubMed ID: 12537516
[TBL] [Abstract][Full Text] [Related]
6. Whole-body physiologically based pharmacokinetic population modelling of oral drug administration: inter-individual variability of cimetidine absorption.
Willmann S; Edginton AN; Kleine-Besten M; Jantratid E; Thelen K; Dressman JB
J Pharm Pharmacol; 2009 Jul; 61(7):891-9. PubMed ID: 19589231
[TBL] [Abstract][Full Text] [Related]
7. Bile flow but not enterohepatic recirculation influences the pharmacokinetics of ranitidine in the rat.
Suttle AB; Brouwer KL
Drug Metab Dispos; 1994; 22(2):224-32. PubMed ID: 8013278
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic drug monitoring and pharmacokinetic compartmental analysis of sulpiride double-peak absorption profile after oral administration to human volunteers.
Helmy SA
Biopharm Drug Dispos; 2013 Jul; 34(5):288-301. PubMed ID: 23585286
[TBL] [Abstract][Full Text] [Related]
9. Variability in cimetidine absorption and plasma double peaks following oral administration in the fasted state in humans: correlation with antral gastric motility.
Takamatsu N; Welage LS; Hayashi Y; Yamamoto R; Barnett JL; Shah VP; Lesko LJ; Ramachandran C; Amidon GL
Eur J Pharm Biopharm; 2002 Jan; 53(1):37-47. PubMed ID: 11777751
[TBL] [Abstract][Full Text] [Related]
10. Gastric pH influences the appearance of double peaks in the plasma concentration-time profiles of cimetidine after oral administration in dogs.
Mummaneni V; Amidon GL; Dressman JB
Pharm Res; 1995 May; 12(5):780-6. PubMed ID: 7479568
[TBL] [Abstract][Full Text] [Related]
11. A pharmacokinetic model for multiple sites discontinuous gastrointestinal absorption.
Plusquellec Y; Efthymiopoulos C; Duthil P; Houin G
Med Eng Phys; 1999 Oct; 21(8):525-32. PubMed ID: 10672785
[TBL] [Abstract][Full Text] [Related]
12. Intestinal uptake of cimetidine and ranitidine in rats.
Mummaneni V; Dressman JB
Pharm Res; 1994 Nov; 11(11):1599-604. PubMed ID: 7870677
[TBL] [Abstract][Full Text] [Related]
13. Comparison of two compartmental models for describing ranitidine's plasmatic profiles.
Schaiquevich P; Niselman A; Rubio M
Pharmacol Res; 2002 May; 45(5):399-405. PubMed ID: 12123628
[TBL] [Abstract][Full Text] [Related]
14. Influence of polyethylene glycol 400 on the gastrointestinal absorption of ranitidine.
Basit AW; Podczeck F; Newton JM; Waddington WA; Ell PJ; Lacey LF
Pharm Res; 2002 Sep; 19(9):1368-74. PubMed ID: 12403075
[TBL] [Abstract][Full Text] [Related]
15. Effect of bupropion on cimetidine and ranitidine absorption in rats.
Tanira MO; Kaka JS; al-Khamis KI
Biopharm Drug Dispos; 1989; 10(1):35-41. PubMed ID: 2493822
[TBL] [Abstract][Full Text] [Related]
16. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
17. Appearance of double peaks in plasma concentration-time profile after oral administration depends on gastric emptying profile and weight function.
Metsugi Y; Miyaji Y; Ogawara K; Higaki K; Kimura T
Pharm Res; 2008 Apr; 25(4):886-95. PubMed ID: 17955185
[TBL] [Abstract][Full Text] [Related]
18. Effect of pancreatico-biliary secretions and GI transit time on the absorption and pharmacokinetic profile of ranitidine in humans.
Reynolds KS; Song MH; Heizer WD; Burns CB; Sica DA; Brouwer KL
Pharm Res; 1998 Aug; 15(8):1281-5. PubMed ID: 9706062
[TBL] [Abstract][Full Text] [Related]
19. Evolution of a detailed physiological model to simulate the gastrointestinal transit and absorption process in humans, part 1: oral solutions.
Thelen K; Coboeken K; Willmann S; Burghaus R; Dressman JB; Lippert J
J Pharm Sci; 2011 Dec; 100(12):5324-45. PubMed ID: 21993815
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal transit and drug absorption.
Kimura T; Higaki K
Biol Pharm Bull; 2002 Feb; 25(2):149-64. PubMed ID: 11853157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
